We’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions. This month we’ve interviewed Jennifer
The Consul General of India, Dr Aman Puri, visited Newcastle upon Tyne yesterday which included a tour of laboratories at QuantuMDx Group Limited (QuantuMDx). As a life science tools and diagnostics company, QuantuMDx
QuantuMDx Group has been awarded ISO 13485: 2016 certification – representing the highest standard of quality a medical devices company can achieve. ISO 13485 is a quality system standard designed
To coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of care diagnostic tools for infectious
Newcastle upon Tyne, UK – 23 January 2018 Life science tools and diagnostics company QuantuMDx announced today it has closed a $12m funding round. As part of this round it
We’re on the precipice of achieving truly monumental strides for gender equality. Progress has been made in recent years to achieve gender equality for women globally; in 46 countries women
2 February 2017, Newcastle upon Tyne, UK QuantuMDx Group announce an assay co-development and commercialisation agreement with The Global Good Fund, managed by Intellectual Ventures, to develop a rapid, low-cost
15 December 2016, Newcastle upon Tyne QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as Non Executive Director. Recognised with
28th November 2016, Newcastle upon Tyne, UK QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration
